MediciNova

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell MediciNova and other ETFs, options, and stocks.

About MNOV

MediciNova, Inc. is a biopharmaceutical company, which engages in the acquisition and development of small molecule therapeutics for the treatment of diseases with unmet medical needs. The company was founded by Yuichi Iwaki on September 26, 2000, and is headquartered in La Jolla, CA. 

CEO
Yuichi Iwaki
CEOYuichi Iwaki
Employees
13
Employees13
Headquarters
La Jolla, California
HeadquartersLa Jolla, California
Founded
2000
Founded2000
Employees
13
Employees13

MNOV Key Statistics

Market cap
76.87M
Market cap76.87M
Price-Earnings ratio
-8.30
Price-Earnings ratio-8.30
Dividend yield
Dividend yield
Average volume
69.06K
Average volume69.06K
High today
$1.50
High today$1.50
Low today
$1.42
Low today$1.42
Open price
$1.45
Open price$1.45
Volume
63.00K
Volume63.00K
52 Week high
$2.66
52 Week high$2.66
52 Week low
$1.26
52 Week low$1.26

MNOV News

TipRanks 2d
MediciNova gets notice of allowance from Japan for pending patent for MN-166

The company states: “MediciNova announced it has received a Notice of Allowance from the Japan Patent Office for a pending patent application which covers MN-16...

Yahoo Finance 2d
MediciNova Receives a Notice of Allowance for a New Patent Covering MN-166 (ibudilast) for the Treatment of Macular ... - Yahoo Finance

MediciNova, Inc. LA JOLLA, Calif., March 26, 2024 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:...

MediciNova Receives a Notice of Allowance for a New Patent Covering MN-166 (ibudilast) for the Treatment of Macular ... - Yahoo Finance
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.